Sonal Khare

Title: Innovations by Sonal Khare in Cancer Therapy

Introduction

Sonal Khare is an accomplished inventor based in Chicago, IL, who has made significant contributions to the field of cancer therapy. With a focus on developing innovative methods for characterizing cancer responses to immune cell-based therapies, she holds 2 patents that reflect her expertise and dedication to improving patient outcomes.

Latest Patents

One of her latest patents is titled "Platform for co-culture imaging to characterize in vitro efficacy of heterotypic effector cellular therapies in cancer." This invention involves a method for characterizing cancer organoid responses to immune cell-based therapy. It includes providing a panel of different combinations of cancer organoid cells and immune cells to culturing wells, where these combinations are cultured under conditions that support organoid growth. Brightfield and corresponding fluorescence images of the culturing wells are captured and analyzed by trained machine learning algorithms. These algorithms identify and distinguish cancer organoid cells from immune cells, characterizing the morphological changes caused by the therapy. An analytical report is generated, detailing the characterization of cancer organoid cell death resulting from the immune cell-based therapy.

Another significant patent is "Determination of cytotoxic gene signature and associated systems and methods for response prediction and treatment." This invention discloses systems, methods, and compositions for treating subjects diagnosed with cancer. The method involves determining whether a tumor sample includes a cytotoxic gene signature and treating the subject based on this determination. The therapy may include one or more checkpoint inhibitors and is applicable to various cancer types, including colorectal, uterine, stomach, lung, skin, head or neck, and non-small cell lung carcinoma.

Career Highlights

Sonal Khare is currently employed at Tempus AI, Inc., where she continues to innovate in the field of cancer research. Her work focuses on leveraging technology to enhance the understanding and treatment of cancer, making her a valuable asset to her organization.

Collaborations

Sonal collaborates with Ameen Salahudeen, contributing to the advancement of cancer therapies through their combined expertise and innovative approaches.

Conclusion

Sonal Khare's contributions to cancer therapy through her patents and work at Tempus AI, Inc. highlight her commitment to improving treatment outcomes for patients. Her innovative methods and collaborative efforts are paving the way for advancements in cancer research and therapy.